Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Stoessl

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Parkinsonism & Related Disorders|October 1, 1996
Which dopamine receptor(s) do we need for motor function? Lessons from gene targeting and translational blockadeA J Stoessl
European Journal of Pharmacology|July 11, 1994
Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxoneA J Stoessl
Advances in Neurology|September 14, 2001
Neurochemical and neuroreceptor imaging with PET in Parkinson's diseaseA J Stoessl
Neuropharmacology|April 1, 1995
Effects of neurotensin in a rodent model of tardive dyskinesiaA J Stoessl
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
Prevention and management of late stage complications in Parkinson's diseaseA J Stoessl
Pharmacology, Biochemistry, and Behavior|July 1, 1996
Effects of ethanol in a putative rodent model of tardive dyskinesiaA J Stoessl
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 19, 1999
Etiology of Parkinson's diseaseA J Stoessl
Brain Research|May 16, 1994
Localization of striatal and nigral tachykinin receptors in the ratA J Stoessl
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2001
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?A J Stoessl
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disordersA J Stoessl
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Parkinsonism & Related Disorders|October 1, 1996
Which dopamine receptor(s) do we need for motor function? Lessons from gene targeting and translational blockadeA J Stoessl
European Journal of Pharmacology|July 11, 1994
Dopamine D1 receptor agonist-induced grooming is blocked by the opioid receptor antagonist naloxoneA J Stoessl
Advances in Neurology|September 14, 2001
Neurochemical and neuroreceptor imaging with PET in Parkinson's diseaseA J Stoessl
Neuropharmacology|April 1, 1995
Effects of neurotensin in a rodent model of tardive dyskinesiaA J Stoessl
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
Prevention and management of late stage complications in Parkinson's diseaseA J Stoessl
Pharmacology, Biochemistry, and Behavior|July 1, 1996
Effects of ethanol in a putative rodent model of tardive dyskinesiaA J Stoessl
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 19, 1999
Etiology of Parkinson's diseaseA J Stoessl
Brain Research|May 16, 1994
Localization of striatal and nigral tachykinin receptors in the ratA J Stoessl
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2001
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it?A J Stoessl
Journal of Psychopharmacology (Oxford, England)|December 14, 2011
Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disordersA J Stoessl
Pageof 10